We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+20.94%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$16.4B
AUM Growth
+$2.8B
(+21%)
Cap. Flow
+$574M
Cap. Flow
% of AUM
3.49%
Top 10 Holdings %
Top 10 Hldgs %
21.48%
Holding
1,573
New
122
Increased
458
Reduced
207
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sunrun
RUN
|
+$59.8M |
| 2 |
Hyliion Holdings
HYLN
|
+$47.2M |
| 3 |
Albemarle
ALB
|
+$41.5M |
| 4 |
Ormat Technologies
ORA
|
+$39.6M |
| 5 |
Hannon Armstrong Sustainable Infrastructure Capital
HASI
|
+$36.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DQ
Daqo New Energy
DQ
|
+$49.1M |
| 2 |
Bright Horizons
BFAM
|
+$36.7M |
| 3 |
Cerence
CRNC
|
+$28M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$27.2M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$24.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 16.65% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 11.64% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
HealthEquity
HQY
$8.83B
| $1.06M | 0.01% |
15,216
+2,900
| +24% | +$180K |
|
802
Toll Brothers
TOL
$14B
| $1.06M | 0.01% |
24,400
-3,700
| -13% | -$172K |
|
803
Lattice Semiconductor
LSCC
$18.2B
| $1.06M | 0.01% |
23,100
| – | – |
|
804
Wyndham Hotels & Resorts
WH
$5.51B
| $1.06M | 0.01% |
17,800
-7,600
| -30% | -$410K |
|
805
Haemonetics
HAE
$4.11B
| $1.06M | 0.01% |
8,895
| – | – |
|
806
ManpowerGroup
MAN
$2.75B
| $1.05M | 0.01% |
11,700
| – | – |
|
807
Herbalife
HLF
$1.28B
| $1.05M | 0.01% |
21,918
+3,900
| +22% | +$188K |
|
808
First American
FAF
$7.56B
| $1.05M | 0.01% |
20,360
| – | – |
|
809
Rexford Industrial Realty
REXR
$8.12B
| $1.05M | 0.01% |
21,402
| – | – |
|
810
AutoNation
AN
$6.89B
| $1.05M | 0.01% |
15,000
+5,400
| +56% | +$340K |
|
811
Exelixis
EXEL
$12.5B
| $1.05M | 0.01% |
52,166
| – | – |
|
812
Marriott Vacations Worldwide
VAC
$4.17B
| $1.04M | 0.01% |
7,577
+1,800
| +31% | +$212K |
|
813
Manhattan Associates
MANH
$11.7B
| $1.03M | 0.01% |
9,788
| – | – |
|
814
Adaptive Biotechnologies
ADPT
$3.89B
| $1.03M | 0.01% |
17,400
| – | – |
|
815
Sonoco
SON
$5.77B
| $1.03M | 0.01% |
17,367
| – | – |
|
816
Watts Water Technologies
WTS
$12.8B
| $1.03M | 0.01% |
8,444
| – | – |
|
817
Vertiv
VRT
$111B
| $1.03M | 0.01% |
+55,000
| New | +$1.01M |
|
|
CDK
818
DELISTED
CDK Global, Inc.
CDK
| $1.03M | 0.01% |
19,814
| – | – |
|
819
Jabil
JBL
$38.8B
| $1.02M | 0.01% |
24,048
| – | – |
|
820
Regal Rexnord
RRX
$11.4B
| $1.02M | 0.01% |
8,323
| – | – |
|
821
AGCO
AGCO
$6.96B
| $1.02M | 0.01% |
9,900
| – | – |
|
822
Douglas Emmett
DEI
$1.99B
| $1.02M | 0.01% |
34,960
| – | – |
|
|
BPMC
823
DELISTED
Blueprint Medicines
BPMC
| $1.01M | 0.01% |
9,051
| – | – |
|
824
Beyond Meat
BYND
$210M
| $1.01M | 0.01% |
8,100
| – | – |
|
825
Omnicell
OMCL
$1.72B
| $1.01M | 0.01% |
8,423
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2020 Portfolio in Review
As of Q4 2020, Handelsbanken Fonder held 1,573 positions worth $16.4B, up 21% from $13.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Handelsbanken Fonder deployed $574M of net new capital in Q4 2020, opening 122 new positions and adding to 458 existing holdings. Its largest new stake was Hyliion Holdings: 2,076,551 shares worth $34.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Daqo New Energy, an estimated $49.1M trimmed.
- Handelsbanken Fonder's largest Q4 2020 buy was Hyliion Holdings: 2,076,551 shares worth $34.2M.
- Handelsbanken Fonder added most to Sunrun in Q4 2020, an estimated $59.8M increase.
- Handelsbanken Fonder's biggest Q4 2020 reduction was Daqo New Energy, cutting an estimated $49.1M.
- Handelsbanken Fonder fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $14M.
- Handelsbanken Fonder's ten largest holdings make up 21% of its $16.4B portfolio in Q4 2020.
- Handelsbanken Fonder opened 122 new positions and closed 28 in Q4 2020.
- Handelsbanken Fonder's portfolio value rose 21% quarter-over-quarter to $16.4B.
Based on Handelsbanken Fonder's 13F filing for Q4 2020, filed 11 Feb 2021.